ABBV Sentiment Analysis
We collect and analyze sentiment surrounding ABBV stock to help you make informed investment decisions.
AbbVie Inc.: A Profitable Pharmaceutical Stock to Consider
Published on December 4, 2024
AbbVie Inc. (ABBV) is one of the most profitable pharmaceutical stocks in the market right now....
ABBVIE INC.: A Leading Pharmaceutical Company with High Institutional Ownership
Published on December 4, 2024
AbbVie Inc. (NYSE: ABBV) is gaining attention in the investment world due to its high institutional ownership....
AbbVie Inc. Continues to Impress with Strong Financial Performance
Published on December 3, 2024
With 73% ownership in AbbVie Inc....
AbbVie Inc. ABBV: A Promising Pharmaceutical Stock with Underrated Potential
Published on December 2, 2024
AbbVie Inc....
AbbVie Inc. ABBV: Leading Pharmaceutical Company Set to Present at Citi's Global Healthcare Conference
Published on December 2, 2024
AbbVie Inc....
ABBVIE INC.: A Leading Pharmaceutical Company with Strong Dividend Potential
Published on November 30, 2024
AbbVie Inc....
AbbVie Inc. Continues to Make Waves in the Healthcare Sector
Published on November 28, 2024
AbbVie Inc. (ABBV) has been making headlines with its recent achievements and developments in the healthcare sector....
AbbVie Executives to Present at Citi's 2024 Global Healthcare Conference
Published on November 27, 2024
AbbVie Inc. (ABBV) has announced that its executives will be presenting at Citi's 2024 Global Healthcare Conference....
AbbVie Inc. Continues to Dominate the Stock Market with Impressive Sales and Product Innovations
Published on November 27, 2024
AbbVie Inc....
AbbVie Inc. Executes Impressive Performance at Citis 2024 Global Healthcare Conference
Published on November 26, 2024
AbbVie Inc....
AbbVie Inc. Offers Exciting Investment Opportunity After Recent Pullback
Published on November 24, 2024
AbbVie Inc....
AbbVie: Upgrading to Strong Buy After Pullback NYSE:ABBV
Published on November 24, 2024
AbbVie Inc....
AbbVie Inc.: A Promising Buy Opportunity for Investors
Published on November 23, 2024
The pharmaceutical giant, AbbVie Inc., stands out as a trending stock on Yahoo Finance....
AbbVie Inc. Continues to Outperform, Stocks Prognosis Forecasts a Strong Buy
Published on November 22, 2024
AbbVie Inc....
Is Trending Stock AbbVie Inc. ABBV a Buy Now Yahoo Finance
Published on November 21, 2024
AbbVie Inc., a leading pharmaceutical company, has been making waves in the stock market recently....
ABBV: 3 Dividend Powerhouses Yielding Over 3% to Consider
Published on November 21, 2024
The renowned company ABBVIE INC. (ABBV) has caught the attention of investors due to its impressive dividend yields....
AbbVie Stock Falls 11% in a Month: Should You Buy the Dip?
Published on November 20, 2024
AbbVie Inc. (ABBV), a renowned biopharmaceutical company, has witnessed an 11% drop in its stock value over the past month....
AbbVie Announces Dividend Increase: Should You Consider Buying the Stock?
Published on November 19, 2024
AbbVie Inc. (NYSE: ABBV), a global biopharmaceutical company, has recently announced an increase in its dividend payout to $1....
AbbVie Inc.: A Promising Future Ahead for Investors
Published on November 18, 2024
In recent news, AbbVie Inc. has caught the attention of investors with its soft earnings report....
Why AbbVie's ABBV Drug Setback Creates A Prime Buy-The-Dip Moment
Published on November 17, 2024
AbbVie Inc. (ABBV) shares took a hit today after disappointing results from its schizophrenia drug trials....
The Motley Fool - AbbVie Stock: Keep Calm And Buy The Dip
Published on November 16, 2024
AbbVie Inc. (ABBV) experienced a decline in stock value today after disappointing results from its schizophrenia drug trials....
AbbVie Faces Setback as Schizophrenia Drug Trials Fall Short
Published on November 14, 2024
Pharmaceutical giant AbbVie Inc....
AbbVie Stock Faces Setback as Schizophrenia Drug Trials Disappoint
Published on November 12, 2024
Shares of AbbVie Inc....
Is Most-Watched Stock AbbVie Inc. ABBV Worth Betting on Now?
Published on November 11, 2024
AbbVie Inc....
Klingman Associates LLC Increases Position in AbbVie Inc. ABBV
Published on November 10, 2024
Klingman Associates LLC, a notable investment firm, recently increased its position in AbbVie Inc. (NYSE:ABBV)....